Author: Alison McCook

Is it possible (or ethical) to have six first authors on a scientific paper?

sci-eng-ethcIn many fields, first authors on scientific papers represent the person who’s performed the bulk of the research. Sometimes, that determination can be difficult to make, so we’ve seen many papers that list multiple first authors, noting that each contributed equally to the work. But is it possible — or ethical — to claim six authors all deserve top billing on a paper?

In a recent letter in Science and Engineering Ethics, Govindasamy Agoramoorthy — at Sengamala Thayaar Educational Trust Women’s College in India and Tajen University in Taiwan — flags a 2014 paper in The Plant Journal that lists six first authors, noting all “contributed equally to this work.”

As Agoramoorthy notes in “Multiple First Authors as Equal Contributors: Is It Ethical?“:  Continue reading Is it possible (or ethical) to have six first authors on a scientific paper?

Researcher who sued to stop retractions earns his 8th

Mario Saad
Mario Saad

Mario Saad, a diabetes researcher who once sued to stop a publisher from retracting his papers, has just received his eighth retraction.

Critical Care has retracted a 2012 paper about treating sepsis, citing extensive similarities between figures within the paper and 10 others.

Here’s the full notice for “Diacerhein attenuates the inflammatory response and improves survival in a model of severe sepsis:” Continue reading Researcher who sued to stop retractions earns his 8th

Two more retractions bring bone researcher’s total to 12

jbmrA bone researcher based in Japan with 10 retractions under his belt has retracted two more papers for similar reasons — problems with the underlying data, and including co-authors who didn’t participate in the project.

In both notices, Yoshihiro Sato is pegged as responsible for the content of the papers. The newly retracted research covers a long timespan — one paper was published in 2000, the other in 2013.

Here’s the first notice, issued by the Journal of Bone and Mineral Research:  Continue reading Two more retractions bring bone researcher’s total to 12

Columbia has settled a fraud case for $9.5M. Here’s why that’s important.

John Thomas
John Thomas

This summer, Columbia University signed a settlement agreement with the U.S. government over a case filed under the False Claims Act (FCA), which enables whistleblowers to sue institutions on behalf of the government. Although this may seem like one of the many legal issues facing academic science recently, this case merits a closer look, says John R. Thomas, Jr., an attorney with Gentry Locke who represents whistleblowers in a variety of FCA cases – including a potentially landmark case against Duke University that we covered for Science. Thomas – who also authored a three-part Retraction Watch primer on how to file an FCA suit (“So You Want to Be a Whistleblower?” Part One, Part Two, Part Three) – tells us what we need to know about this latest FCA verdict.

As readers of Retraction Watch are unfortunately well aware, dishonesty in research comes in many forms. While we often focus on dishonesty in research itself, scientists and institutions may also defraud the government through a variety of administrative avenues, such as effort reporting (accounting for researcher time), improper cost accounting, and inflated facilities and administrative (F&A) costs.

We saw an example of this in July, when Continue reading Columbia has settled a fraud case for $9.5M. Here’s why that’s important.

No academic post for fraudster Diederik Stapel, after all

stapel_npc
Diederik Stapel

Recently, we reported that social psychologist and renowned data faker Diederik Stapel had found himself a new gig supporting research at a vocational university in the Netherlands — but it appears that was short-lived.

According to multiple news reports, NHTV Breda will not be employing Stapel, after all.

Here’s our Google translate of a portion from De Telegraaf: Continue reading No academic post for fraudster Diederik Stapel, after all

How can we improve preclinical research? Advice from a diabetes researcher

Daniel Drucker
Daniel Drucker

By all accounts, science is facing a crisis: Too many preclinical studies aren’t reproducible, leading to wasted time and effort by researchers around the world. Today in Cell Metabolism, Daniel Drucker at the Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital in Toronto details numerous ways to make this early research more robust. His most important advice: more transparent reporting of all results (not just the positive findings), along with quantifying, reporting, tracking, and rewarding reproducibility, for both scientists and journals and universities/research institutes.

Retraction Watch: Which of your recommendations will researchers most object to, and why? Continue reading How can we improve preclinical research? Advice from a diabetes researcher

Meet the filmmakers who cracked open the case against star surgeon Macchiarini

svtlogo-black_v2Paolo Macchiarini — once a world-renowned surgeon for creating tracheas from cadavers and patients’ own stem cells – has been dogged for years by accusations of misconduct. Officials at his institution, Karolinska Institute, initially cleared him of many charges, but that all changed earlier this year, when Swedish Television (SVT) aired a series of documentaries about Macchiarini and his work. The series alleged, in part, that he operated on patients in Russia whose conditions were not life-threatening enough to warrant such a risky procedure. Such serious accusations caused a media storm, and prompted officials to take a second look at Macchiarini’s work. KI dismissed Macchiarini, and many others have resigned, including KI’s vice chancellor. Recently, two new reports critiqued KI’s role in the case, and Sweden’s Central Ethical Review Board found Macchiarini guilty of misconduct in a 2014 paper. We spoke with SVT producers Bosse Lindquist and Johannes Hallbom via email about the fallout from their series.

Retraction Watch: Your documentary series has caused quite a storm: A series of resignations and renewed investigations have followed. Are you surprised by the reaction? Continue reading Meet the filmmakers who cracked open the case against star surgeon Macchiarini

Danish court dismisses charges against neuroscientist in appeal of fraud verdict

court-caseA Copenhagen court has cleared neuroscientist Milena Penkowa of the most serious charges against her after she appealed a 2015 verdict that she had faked data.

According to the CPH Post, the Eastern High Court in Copenhagen dismissed the case. Although the court acknowledged she had committed fraud, it declared it was not “serious forgery.”

On Facebook, Penkowa posted a message (according to the Facebook translation): Continue reading Danish court dismisses charges against neuroscientist in appeal of fraud verdict

Do scientific manuscripts need cover letters?

James Kenar
James Kenar

How important is it to include a cover letter with a manuscript submission?

It seems that opinions differ. A 2013 article in Science Careers asked if it was a “relic;” but in a recent editorial, a journal editor reassures his readers that yes, he reads every cover letter — and yes, it’s important. (If you agree with him, let us know in our poll, below.)

In “Dear Authors: We Do Read Your Cover Letters,” James Kenar, editor of the Journal of the American Oil Chemists’ Society, insists on their importance: Continue reading Do scientific manuscripts need cover letters?

Posts you may have missed: Student loses PhD, controversial data to be released

RW logoWe’ve got some late-breaking news to report — plus, it’s been a busy news week overall, and some of our email alerts didn’t go out, due to a programming glitch. Below, here are some recent stories you may have missed.

A tribunal at Queen Mary University of London has decided to disclose the data from the controversial PACE trial, which tested various therapies for chronic fatigue syndrome. For critics of this study, this has been a long-awaited decision.

What’s more,  Continue reading Posts you may have missed: Student loses PhD, controversial data to be released